When independent scientific advice helps a clinical research programme

What a scientific consultant does, and does not

A scientific consultant brings senior, independent judgement to a specific question: is this the right target, the right endpoint, the right design. The consultant does not run the study, hold the data, submit to regulators or act as sponsor. Those roles belong to the team, its CRO and its regulatory advisers; good consultancy makes their work sharper.

Five moments where it pays

1. Concept and endpoint choice. Before the protocol exists, when the question can still change.
2. Protocol review before ethics submission. A fresh reader finds the ambiguities a committee will find.
3. Interim decisions and publication strategy. When results arrive and the team must decide what they mean and where they belong.
4. Scientific due diligence. When an investor or partner needs an independent view of a programme's evidence.
5. Grant narratives. When a strong idea needs the structure and framing a panel expects.

How to choose an adviser

Look for independence, declared conflicts of interest, deliverables that cite their evidence, and a named person who does the work. Be cautious of advice that promises outcomes, publication in named journals or regulatory success; none of these can honestly be guaranteed.

What to prepare for a first call

A one-page summary of the question, the current design or data, the decision you need to make and its deadline. Anonymised or aggregated information is enough for a first conversation. If confidential material must be shared, sign a mutual NDA first and share it through a protected channel.

Confidentiality and data

Do not send patient-identifiable or participant-level data to an adviser. Good Clinical Practice, the estimand framework and, in the EU, the Clinical Trials Regulation define the standards a design must meet; trial registration before enrolment remains a condition of publication in most journals.